Predictor of mortality and rehospitalization of acute decompensated heart failure at six months follow up

Critical Care and Shock

Volumn 9, Issue 3, 2006, Pages 61-67

  Siswanto, B B ^a   Sunanto, ^a   Munawar, M ^a   Kusmana, D ^a   Hanafiah, A ^a   Waspadji, S ^a   Bachtiar, A ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Heart failure; Mortality; N terminal proBNP; Rehospitalization

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; HEMOGLOBIN; HYDRALAZINE; LACTIC ACID; NITRATE; SODIUM;

ACUTE HEART FAILURE; ADULT; ANAMNESIS; ARTICLE; BLOOD EXAMINATION; BODY MASS; COHORT ANALYSIS; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART VENTRICLE HYPERTROPHY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INDONESIA; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT DEPARTMENT; PHYSICAL EXAMINATION; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; THORAX RADIOGRAPHY;

EID: 33748342513     PISSN: 14107767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mendez GF, Cowie MR (2001) The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol 80:213-219
2. Cleland JG, Khand A, Clark A (2001) The heart failure epidemic: exactly how big is it? Eur Heart J 22:67676-683
3. Utami S, Suparno, Meilantoro (1999) Harapan Kita National Health Center Year Report. Jakarta, pp 17-25
4. Utami S, Suparno, Meilantoro (2000) Harapan Kita National Health Center Year Report. Jakarta, pp 32-39
5. Utami S, Suparno, Meilantoro (2001) Harapan Kita National Health Center Year Report. Jakarta, pp 42-8
6. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88:107-115
7. Rodriguez-Artalejo F, Guallar-Castillon P, Pascual CR, Otero CM, Montes AO, Garcia AN, Conthe P, Chiva MO, Banegas JR, Herrera MC (2005) Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med 165:1274-1279
8. Deedwania PC (2003) The key to unraveling the mystery of mortality in heart failure: an integrated approach. Circulation 107:1719-1721
9. van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI (1992) Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 70:359-363
10. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlof B; LIFE Study Investigators (2006) Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for End-point Reduction in Hypertension (LIFE) study. Circulation 113:67-73
11. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203-210
12. Hare JM, Johnson RJ (2003) Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 107:1951-1953
13. Martinez A, Gonzalez A, Cerda C, Perez P, Castro P, Perez O, Isa R, Corbalan R (2004) Prognostic value of hyperuricemia in chronic heart failure. Rev Med Chil 132:1031-1036
14. De Luca L, Klein L, Udelson JE, Orlandi C, Sardella G, Fedele F, Gheorghiade M (2005) Hyponatremia in patients with heart failure. Am J Cardiol 96:19L-23L
15. Palatini P (2001) Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med 33:213-221
16. Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, Rousseau MF (2000) Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 6:201-207
17. Burger MR, Burger AJ (2001) BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential. Curr Opin Investig Drugs 2:929-935
18. Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P, Carbonieri E, Ceci V, Cerisano S, Barro S, Milani L (2005) B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 11(7):498-503.
19. McCord J, Nowak RM, Jacobsen G, Sallach JA, Wu AH, Perez A, Omland T, Knudsen CW, Westheim A, Duc P, Steg PG, Hollander JE, Herrmann HC, Storrow AB, Abraham WT, Lamba S, McCullough PA, Maisel A (2005) B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction. Am J Cardiol 96:1370-1373
20. Prontera C, Emdin M, Zucchelli GC, Ripoli A, Passino C, Clerico A (2004) Analytical performance and diagnostic accuracy of a fully-automated electrochemiluininescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Clin Chem Lab Med 42:37-44
21. Meregalli A, Oliveira RP, Friedman G (2004) Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care 8:R60-R65
22. Bozkurt B, Deswal A (2005) Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 150:1233-1239
23. Roguin A, Behar D, Ben Ami H, Reisner SA, Edelstein S, Linn S, Edoute Y (2000) Long-term prognosis of acute pulmonary oedema-an ominous outcome. Eur J Heart Fail 2:137-144
24. Williams SG, Jackson M, Cooke GA, Barker D, Patwala A, Wright DJ, Albuoaini K, Tan LB (2005) How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure? Am Heart J 150:983
25. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN; Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure (2002) QRS duration and mortality in patients with congestive heart failure. Am Heart J 143:1085-1091
26. Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40-48
27. Lonn E, Mathew J, Pogue J, Johnstone D, Danisa K, Bosch J, Baird M, Dagenais G, Sleight P, Yusuf S; Heart Outcomes Prevention Evaluation Study Investigators (2003) Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients. Eur J Cardiovasc Prev Rehabil 10:420-428
28. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R (1993) Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87:VI5-VI16
29. Faris R, Coats AJ, Henein MY (2002) Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern. Am Heart J 144:343-350
30. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 26:357-366
31. Heart Failure Society Of America (2006) HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail Card Fail 12:e1-e2
32. Grigorian-Shamagian L, Varela-Roman A, Mazon-Ramos P, Pedreira-Perez M, Rigueiro-Veloso P, Ramon Gonzalez-Juanatey J (2005) Anemia as a new predictor of mortality in patients hospitalized with congestive heart failure. Med Clin (Barc) 125:647-653
33. Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C (2002) C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 4:331-336
34. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA (2004) Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110:1780-1786
35. Dokainish H, Zoghbi WA, Ambriz E, Lakkis NM, Quinones MA, Nagueh SF (2006) Comparative cost-effectiveness of B-type natriuretic peptide and echocardiography for predicting outcome in patients with congestive heart failure. Am J Cardiol 97:400-403
36. Bettencourt P, Frioes F, Azevedo A, Dias P, Pimenta J, Rocha-Goncalves F, Ferreira A (2004) Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 93:45-48
37. Collucci WS (2002) Brain Natriuretic Peptide as a predictor of remodeling in heart failure. In: Narula J (Ed) Heart Failure: Pathogenesis and Treatment. Martin Dunitz, London, pp 188 - 189